Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

As AI smartphones reach a critical juncture, major manufacturers are ramping up their hardware and AI application development ...

From scuffs and scratches to OS updates, here are the seven major factors that can minimize your phone's resale value ...

Catch a first look at the vivo Y300 5G's features and pricing ahead of its launch. Discover why this could be your next smartphone.

The Vivo X200 series is expected to arrive in India soon, with a possible launch slated for December 2024. Here are 8 key ...

Infection research stands at the forefront of global health initiatives, particularly considering emerging pathogens and ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

Type 2 Diabetes, In Vivo Model, High-Voltage Electrotherapy, Glucose Tolerance Test (GTT), Hematological Analysis Kriman, V. (2024) Study of the Effect of High-Voltage Low-Frequency Electrotherapy on ...

Vivo’s Y18 series is composed of three distinct smartphones, the devices are namely the Vivo Y18, Y18i, and Y18e. Today, the smartphone maker unveiled a “t” model as the fourth member in this lineup .

In vivo proof-of-concept data from Prime Medicine’s GalNAc-LNP Prime Editor for the treatment of Wilson’s Disease, demonstrated up to 80% precise correction of the H1069Q mutation and restoration of ...